Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Ritlecitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 12,194Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aclaris ITK/JAK3 Inhibitor Shows Hair Regrowth in Alopecia Model
    Aclaris ITK/JAK3 Inhibitor Shows Hair Regrowth in Alopecia Model

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226283/37216/en/Aclaris-Therapeutics-Novel-ITK-JAK3-Inhibitor-ATI-2138-Demonstrates-Rapid-and-Sustained-Hair-Regrowth-in-Validated-Murine-Model-of-Alopecia-Areata-AA.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    UK regulator approves Pfizer's hair loss drug
    UK regulator approves Pfizer's hair loss drug

    02 Nov 2023

    // HEALTH ET

    https://health.economictimes.indiatimes.com/news/pharma/drug-approvals-launches/uk-regulator-approves-pfizers-hair-loss-drug/104890544

    HEALTH ET
    02 Nov 2023
    Share Share
    European Commission Approves Pfizer’s LITFULO™ for Severe Alopecia Areata
    European Commission Approves Pfizer’s LITFULO™ for Severe Alopecia Areata

    19 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230918672148/en

    BUSINESSWIRE
    19 Sep 2023
    Share Share
    Pfizer Receives Positive CHMP Opinion for Alopecia Areata Treatment
    Pfizer Receives Positive CHMP Opinion for Alopecia Areata Treatment

    22 Jul 2023

    // PRESS RELEASE

    https://www.pfizer.com/news/announcements/pfizer-receives-positive-chmp-opinion-alopecia-areata-treatment

    PRESS RELEASE
    22 Jul 2023
    Share Share
    FDA approves Pfizer’s Litfulo for patients with severe alopecia areata
    FDA approves Pfizer’s Litfulo for patients with severe alopecia areata

    26 Jun 2023

    // Betsy Goodfellow PHARMAFILE

    https://pharmafile.com/news/fda-approves-pfizers-litfulo-for-patients-with-severe-alopecia-areata/

    Betsy Goodfellow PHARMAFILE
    26 Jun 2023
    Share Share
    US FDA approves Pfizer's hair loss drug
    US FDA approves Pfizer's hair loss drug

    24 Jun 2023

    // PRESS RELEASE

    https://www.pfizer.com/news/press-release/press-release-detail/fda-approves-pfizers-litfulotm-ritlecitinib-adults-and

    PRESS RELEASE
    24 Jun 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.